INTRODUCTION
Dendritic cells (DCs) are the most potent antigen-presenting cells (APCs) known to trigger T cell immunity. Their interaction with T lymphocytes is a key event in the early stages of a primary immune response [1] . Because of their capacity to stimulate naive T cells, DCs are considered promising tools and targets for immunotherapy [2] . In peripheral tissues, immature DCs (imDCs) capture antigens and upon contact with inflammatory factors or microbial components, migrate to the lymphoid organs to undergo a maturation process [3] . They express high levels of costimulatory and accessory molecules, up-regulate major histocompatibility complex (MHC) class I and II molecules, and express CD83. They also produce high levels of immunoregulatory cytokines including interleukin (IL)-10 and IL-12 [4] . Mature DCs (mDCs) can activate naïve, antigen-specific T lymphocytes, leading to memory T cell expansion and differentiation of effector T cells, thus providing immediate protection against pathogens in peripheral tissues [5, 6] . At the sites of inflammation, cytokines and chemokines promote the activation of resident DCs and the recruitment of DC precursors, which may permeate peripheral tissues, including the skin, where they receive stimuli from local infection or inflammation [7] . Peripheral blood monocytes can differentiate into DCs or macrophages depending on environmental factors encountered in peripheral tissues [8, 9] . Upon contact with granulocyte macrophage-colony stimulating factor (GM-CSF) and IL-4, cytokines produced by tissue mast cells, CD14 ϩ monocytes differentiate in competent imDCs [10 -12] . Different signals of infection, inflammatory cytokines such as tumor necrosis factor ␣ (TNF-␣), or phagocytosis have been demonstrated to interfere with DC differentiation [13, 14] . Many pathogens have evolved mechanisms to exploit DC biology in their dissemination within the body and/or to interfere with DC functions to block or delay their elimination by the host. Several pathogens or their components can interact with imDCs or their precursors, influencing DC generation [15, 16] . Recently, it has been demonstrated that a typical intracellular pathogen, Mycobacterium tuberculosis, is able to subvert the differentiation of infected monocytes into DCs, suggesting an escape mechanism, which contributes to mycobacterial, intracellular persistence [17] .
To date, tuberculosis is the sixth largest cause of death, and the death rate is growing with an estimated annual increase of 3% [18] . The bacillus Calmette-Guerin (BCG) strain is a live vaccine that has been used in routine vaccination for nearly 80 years. Although it is almost nonpathogenic, it retains the immunogenic properties of M. tuberculosis [19] . BCG is effective in protecting severe forms of disseminated tuberculosis, such as meningitis, in childhood [20] ; however, its efficacy in protecting adult pulmonary tuberculosis has remained stunningly variable [21, 22] . The failure of BCG vaccination may be at least partially explained by the induction of poor or inappropriate host responses [23] . However, the reasons explaining the failure of BCG still need to be fully resolved. DCs are likely to play a key role in the induction of immune response to M. tuberculosis by polarizing T lymphocyte reactivity toward a T helper cell type 1 (Th1) profile, contributing to the generation of protective cellular immunity against mycobacteria [24] .
In the present work, we investigated the effects of BCG on the differentiation of monocytes into imDCs and mDCs. We isolated peripheral blood monocytes from healthy donors, infected with BCG, and then cultured them with GM-CSF and IL-4. We found that imDCs derived from BCG-infected precursors acquired a mature phenotype, produced IL-10, and directed a Th2-like immune response. These findings could explain one of the mechanisms underlining the failure of the BCG vaccine to prevent pulmonary tuberculosis.
MATERIALS AND METHODS

Mycobacteria
In all experiments, BCG vaccine from Aventis Pasteur (Paris, France) has been used. Lyophilized BCG was resuspended in physiologic solution at ϳ1 ϫ 10 6 colony-forming units (CFU) per 100 l. BCG viability was verified by CFU assay.
Monocyte purification and infection and DC generation
Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats of healthy donors by density gradient centrifugation using Lympholyte-H (Cederlane, Canada). Monocytes were positively separated by anti-CD14 magnetic beads [magnetic cell sorter (MACS), Miltenyi Biotec, Germany], according to the manufacturer's instructions. The cells were then resuspended in RPMI 1640 (Euroclone, UK), supplemented with 10% fetal calf serum (BioWhittaker, Belgium), L-glutamine (2 mM), Hepes buffer (10 mM), sodium piruvate (0.1 M), nonessential amino acids (0.1 M, Euroclone), and gentamycin (10 g/ml, Sigma-Aldrich, Germany). Monocytes were infected for 3 h with single-cell suspensions of BCG at a multiplicity of infection (MOI) of 1 or were stimulated with lipopolysaccharide (LPS; from Escherichia coli, 1 g/ml, Sigma-Aldrich). The infection was carried out in the absence of antibiotics. After the treatment, monocytes were washed and cultured with fresh, complete medium for 5 days in the presence of GM-CSF (200 U/ml) and IL-4 (10 ng/ml, Euroclone) to generate imDCs. To induce final maturation of imDCs, LPS (200 ng/ml) was added at the fifth day of culture for 2 days further. Viability of infected cells was determined by trypan blue exclusion.
Fluorescein-activated cell sorter (FACS) analysis
The following fluorescein isothiocyanate (FITC)-or phycoerythrin (PE)-conjugated antibodies-anti-human leukocyte antigen (HLA) class I, HLA-DR, CD1a, CD11c, CD14, CD40, CD64, CD80, CD83, CD86, and CCR7 (Becton Dickinson Bioscience, Mountain View, CA)-were used for direct immunofluorescence staining to characterize the phenotype of DCs generated in different conditions. Briefly, the cells were washed twice in phosphate-buffered saline (PBS), 1% bovine serum albumin (BSA), and 0.1% sodium azide and were stained with the monoclonal antibodies (mAb) for 15 min at 4°C. The cells were then washed and acquired using a FACSCalibur instrument running Cellquest software (Becton Dickinson Bioscience).
Transwell experiments
In Transwell experiments, the infected and uninfected monocytes were separated by a membrane (6.5 mm diameter, 0.4 m pore size) in 24-well plates (Corning-Costar, Cambridge, MA). The lower compartment of the wells contained untreated monocytes (1ϫ10 6 cells); the upper compartments contained untreated cells or BCG-infected or LPS-treated monocytes (1ϫ10 6 cells). The cells were cultured in the presence of GM-CSF and IL-4 in 2 ml culture medium. After 5 days, the cells were harvested from the lower and upper compartments, stained with the anti-CD1a mAb, and analyzed for the CD1a expression by FACS.
Confocal laser-scanning microscopy (CLSM) analyses
For CLSM analyses, 5 ϫ 10 5 DCs were added per well in a U-bottom microtiter plate and were washed once with PBS containing 0.2 mM NaN 3 and 1% BSA. Cells were incubated (30 min, ϩ4°C) with appropriate dilution of anti-CD1a-FITC or antiactin-PE mAb. After extensive washes, the cells were fixed with 3% paraformaldehyde, washed once, and mounted on the microscope slide with the Prolong antifade reagent (Molecular Probes, Eugene, OR). The control samples were treated in the same way. For intracellular staining, the cells were fixed and permeabilized with cold methanol (-20°C, 10 min) and then incubated with the antibody for 30 min at 37°C.
CLSM observations were done using a Leica TCS 4D apparatus, equipped with an Argon-Krypton laser, dichroic splitter (488 nm), and 520 nm long-pass filter for observations with FITC-conjugated antibody. Image acquisition and processing were conducted by using the Scanware (Leica Lasertechnik GmbH, Heidelberg, Germany) and Adobe Photoshop software programs.
Cytokine assay
Supernatants of DCs derived from treated or untreated precursors were collected at the fifth day of culture or after stimulation with LPS (200 ng/ml) for 48 h and were stored at -80°C. The levels of IL-10, IL-12, TNF-␣, IL-1␤, and IL-6 were determined by enzyme-linked immunosorbent assay (ELISA) kits (Pierce, Endogen, Woburn, MA), according to the manufacturer's instructions. Supernatants of cord-blood mononuclear cells (CBMCs) and purified CD4 ϩ CD45RA ϩ T cells cocultured with DCs generated from untreated, BCGinfected, or LPS-treated monocytes were tested for IL-4 and interferon-␥ (IFN-␥) using commercially available ELISA kits (Pierce, Endogen). Results are expressed as pg/ml. ϩ CD45RA ϩ T cells were purified by incubating CBMCs with anti-CD45RA MACS (Miltenyi Biotec). According to the manufacturer's instruction, after O/N incubation to allow beads degradation, CD4 ϩ T cells were purified further. Supernatants were collected and analyzed for cytokine accumulation.
T lymphocyte proliferation and functional polarization
Statistical analysis
Statistical analysis was determined using a Student's t-test. Values of P Ͻ 0.05 were considered statistically significant.
RESULTS
Phenotypic characterization of DCs derived from BCG-infected precursors
Human monocytes were purified from buffy coats of healthy donors and infected with BCG at MOI of 1 or treated with LPS (1 g/ml) for 3 h and then cultured in complete medium containing GM-CSF and IL-4 for 5 days. Human monocytes developed into imDCs, characterized by the acquisition of CD1a and the loss of CD14 molecules. In contrast, imDCs, generated from BCG-infected monocytes, did not express CD1a on their surfaces (Fig. 1) . Moreover, imDCs derived from LPS-treated monocytes showed only a slight reduction in the expression of CD1a. However, BCG-DCs and LPS-DCs were CD14 -( Fig. 1 ) and CD64 -(data not shown), suggesting that they were not blocked at the monocyte/macrophage stage. Furthermore, BCG-DCs at the fifth day of culture expressed higher levels of MHC class I and class II and CD80 and CD86 costimulatory molecules than imDCs in the absence of maturation stimuli. In contrast, the phenotype of LPS-DCs was similar to that of imDCs except for the expression of MHC class II, which was up-regulated. It is interesting that BCG-DCs acquired the phenotype of mDCs at the fifth day of culture, as shown by the expression of the maturation markers such as CD83 and CCR7. The presence of CCR7 suggests that the infection is sufficient to induce migratory receptor expression required by mDCs to reach lymphoid organs. Following stimulation with LPS (200 ng/ml) for 48 h, BCG-DCs did not further up-regulate their maturation markers. Moreover, imDCs and LPS-DCs, after stimulation with LPS, acquired a mature phenotype, showing the increase of MHC class I and class II, CD80 and CD86, and the induction of CD83 and CCR7. The histograms in Figure 1B show the mean of 10 experiments performed. Taken together, these results suggest that BCGinfected monocytes differentiate into CD1a -DCs with a mature phenotype able to migrate to lymphoid organs.
BCG-monocyte interaction is necessary to generate BCG-DCs
To investigate whether the generation of BCG-DCs was a result of the interaction of BCG with monocytes or to soluble factors produced upon BCG infection, we performed a set of Transwell experiments. The untreated monocytes were cultured in the lower chambers, and untreated, BCG-infected, or LPS-treated monocytes were placed into the upper chambers in the presence of GM-CSF and IL-4 for 5 days. The CD1a expression of the resulting DC populations in the lower and upper chambers was analyzed by FACS. DCs derived from monocytes cultured in the lower chamber were CD1a ϩ in all culture conditions, whereas BCG-DCs did not express CD1a (Fig. 2) . This suggests that the CD1a -phenotype of BCG-DCs requires the interaction of monocytes with BCG and is not a result of a soluble factor produced by infected cells.
Distribution of CD1a molecules in BCG-DCs
It has been described that DCs with the CD1a -phenotype generated in different experimental conditions have the capacity to produce IL-10 and to polarize T cells toward a Th2 response [25, 26] . Conversely, it has been reported that mycobacterial infections interfere with the surface expression of CD1 molecules [27] and that mycobacterial antigens interact with different members of the CD1 family [28, 29] . To investigate whether BCG-DCs are a subset derived from distinct precursors giving rise to the CD1a -DC population or whether the down-modulation of CD1a is induced by the infection, we analyzed the distribution of CD1a by confocal microscopy. The cells were analyzed by dual immunofluorescence staining using CLSM analyses at the fifth day of culture. imDCs and BCGDCs were fixed with cold methanol and labeled with antiCD1a-FITC-conjugated and antiactin-PE-conjugated mAb for the intracellular staining. As demonstrated by merging the CD1a and actin staining, BCG-DCs did not express the CD1a molecules on the surface, but CD1a molecules were present in the intracellular compartment (Fig. 3) . This suggests that BCG induces a down-modulation of CD1a, interfering with the differentiation of monocytes into DCs and not inducing the selection of a distinct DC subset.
T cell stimulation by BCG-DCs
To test whether the differentiation of infected precursors into BCG-DCs induces an alteration of their antigen-presenting capacities, imDCs or DCs derived from BCG-infected or LPStreated precursors were cocultured with allogeneic PBMCs isolated from healthy donors at various DC:T cell ratios before and after induction of maturation in the presence of LPS (Fig.  4) . Although BCG-DCs showed at the fifth day of culture the up-regulation of MHC class I and class II and CD80 and CD86 molecules, they were not more efficient to stimulate allogeneic PBMCs compared with imDCs and LPS-DCs. However, upon further maturation stimuli, BCG-DCs increased their antigenpresenting capacity as well as imDCs and LPS-DCs (Fig. 4) , suggesting that they are able to acquire the functions of fully mDCs.
Cytokine production by BCG-DCs
The secretion of proinflammatory cytokines by DCs, such as TNF-␣, IL-1␤, and IL-6 in imDCs, BCG-DCs, and LPS-DCs was evaluated at the fifth day of culture by ELISA. Uninfected DCs were not able to produce TNF-␣ and IL-1␤ cytokines but only low amounts of IL-6 in the absence of maturation stimuli (Fig. 5) . Similar results were obtained by DCs generated from LPS-treated monocytes, although they secreted high levels of IL-6. In contrast, BCG-DCs produced high levels of TNF-␣, IL-1␤, and IL-6, showing that they have acquired an activated phenotype. Furthermore, the accumulation of IL-10 and IL-12, which are important factors involved in directing immune response, was measured at the fifth day of culture or after LPS stimulation. In the absence of maturation stimuli, imDCs did not produce IL-12 or IL-10, and after LPS stimulation, the production of IL-12 was induced as previously reported (Fig.  6) . Conversely, DCs generated from LPS-treated monocytes secreted high amounts of IL-12 and low levels of IL-10 at the fifth day of culture and after maturation stimuli. In contrast, BCG-DCs produced high levels of IL-10 and were not able to produce IL-12 before or after LPS stimulation. These data indicate that BCG-infected monocytes are able to differentiate into DCs that produce proinflammatory cytokines and IL-10 at 5 days of culture or upon maturation stimuli.
BCG-DCs induce IL-4 production in CBMCs
DCs have the ability to stimulate naive T lymphocytes and drive them into distinct classes of effector cells. Because of the particular pattern of cytokines produced by BCG-DCs, we speculated that this population of DCs could differ in its capacity to support T cell differentiation. imDCs, LPS-DCs, and BCG-DCs were cultured in the presence of human CBMCs or CD4 ϩ CD45RA ϩ T cells for 8 days. CBMCs cultured with LPS-DCs or untreated DCs produced high levels of IFN-␥ and significantly less IL-4 (Fig. 7A) . In contrast, CBMCs cultured with BCG-DCs produced high levels of IL-4 and a low amount of IFN-␥. Conversely, CD4 ϩ CD45RA ϩ T cells cocultured with BCG-DCs are not able to produce IFN-␥ or IL-4 compared with 
CD4
ϩ CD45RA ϩ T cells stimulated with LPS-DCs, which produced IFN-␥ as expected (Fig. 7B) . These data show that BCG-infected monocytes differentiate into DCs inducing a Th2-like response and are unable to induce the production of IFN-␥, which is necessary to elicit a protective, immune response against mycobacteria.
DISCUSSION
In this work, we describe the generation of a phenotypically and functionally monocyte-derived DC population that lacks IL-12 production, secretes increased levels of IL-10, and directs differentiation of T cell precursors toward the Th0/Th2-like phenotype. These cells were generated from human peripheral blood monocytes infected with tuberculosis vaccine BCG and cultured in the presence of GM-CSF and IL-4. These cytokines are released during inflammatory processes and sensitization procedures, including the vaccination with BCG, activating sequential production of Th1 and Th2 cytokines [30] .
In the pathology of tuberculosis, the early interaction between DCs, present as a dense network in the airway mucosa, and M. tuberculosis is likely to be critical for mounting a protective, antimycobacterial immune response [31, 32] . However, M. tuberculosis infection remains much of the time in the lifetime of the host. The unique function of DCs in eliciting and directing the cellular immune response may be modulated by mycobacteria [33] [34] [35] . Recently, it has been demonstrated that M. tuberculosis is able to subvert DC differentiation of infected monocytes to escape immune response [17] .
The benefits of the only available tuberculosis vaccine, BCG, in the protection against M. tuberculosis have been debated since early in its use, including safety aspects, loss of sensitivity to tuberculin as a diagnostic reagent, and in particular, the failure of BCG in a number of trials in the Third World. There have been many hypotheses to explain the inadequate, protective effect of BCG against tuberculosis as the lack of an effective stimulation of T cell populations [23] . However, to develop a novel vaccine strategy superior to BCG, fundamental immunological mechanisms responsible for protection, as well as reasons explaining the failure of BCG, still need to be fully resolved [36, 37] .
We investigated whether the infection of monocytes with BCG could interfere with their differentiation into DCs and analyzed the capacity of BCG-DCs to direct T cell immune response. We found that BCG-infected monocytes differentiate into cells with an acquired, mature phenotype, as when they lose CD14, they express CD83 and up-regulate CD80, CD86, and MHC class I and class II molecules in the absence of maturation stimuli. In addition, DCs generated from BCGinfected monocytes express the CCR7 on their surface. The expression of this chemokine receptor in BCG-DCs is particularly relevant, as it allows homing to secondary lymphoid organs, where DCs can present antigens to specific T lymphocytes [38] . It is known that during the differentiation of precursors into DCs, the cells acquire CD1a molecules on their surface, allowing them to present lipid and glycolipid antigens to T lymphocytes. However, BCG-DCs do not express CD1a molecules on their surface. In contrast, we found by confocal analyses that CD1a molecules are sequestrated in intracellular compartments. This finding is in accordance to previous investigations revealing that CD1 expression can be down-regulated by mycobacteria in infected DCs [39, 40] . Conversely, LPStreated monocytes differentiate into imDCs, showing a phenotype similar to the untreated cells except for the MHC class II up-regulation, suggesting that the treatment of monocytes with inflammatory stimuli does not completely account for the generation of DCs, presenting an early, mature phenotype. Although BCG-DCs show a mature phenotype at the fifth day of culture, they are not more efficient in stimulating T cells compared with imDCs and LPS-DCs. However, upon further maturation stimuli, their antigen-presenting capacity is increased, showing that they are able to acquire the capacity of fully mDCs.
In addition, BCG-DCs acquire an activated phenotype at the fifth day, as they produce proinflammatory cytokines such as TNF-␣, IL-1␤, and IL-6, showing that they are able to elicit an inflammatory, immune response. It has been reported that the production of proinflammatory cytokines by APCs promotes the recruitment and activation of additional leukocytes, playing a central role to limit the growth of intracellular pathogens [41] .
DCs are known for their capacity to produce immunoregulatory cytokines such as IL-12 or IL-10 upon maturation stimuli. Therefore, the balance of the production of these cytokines plays a pivotal role by orchestrating an innate and acquired immune response and determining the polarization of T cell precursors [42, 43] . It is interesting that we found that BCGDCs, before or after maturation stimuli, produce high levels of IL-10 and are not able to produce IL-12 levels comparable with imDCs. Conversely, LPS-DCs secrete IL-12 and not IL-10 at the fifth day of culture or after a further LPS-induced maturation. The apparent disagreement of our findings with earlier studies, which showed that BCG is a trigger of IL-12 production of mDCs, can be reconciled on the grounds that cytokine production is modulated differentially, depending on the timing and the maturation stage of target cells. Indeed, in our model, we infected human monocytes and not differentiated DCs, as it was in other experimental studies [44, 45] . The secretion of IL-10 and the inhibition of IL-12 synthesis can account for the inability of BCG-DCs to induce the expansion of effector Th1 lymphocytes. Indeed, BCG-DCs induce a Th2-like immune response when cultured with CBMCs, as shown by high levels of IL-4 and low amounts of IFN-␥ production. However, the production of IL-10 by BCG-DCs cannot completely be taken into account for the IL-4 production, as neutralizing anti-IL-10 antibodies did not reverse the cytokine profile (data not shown). Furthermore, purified CD4 ϩ CD45RA ϩ T cells cocultured with BCG-DCs were not able to produce IL-4 or IFN-␥. These results could be explained by the presence of multiple cell types in CBMCs able to produce IL-4 such as CD8ϩ T cells. The loss of IFN-␥-producing T cells could be associated with a nonprotective, immune response and an ineffective role in the killing of intracellular bacteria by macrophages. Several studies indicate that the IFN-␥ is the key cytokine in the control of M. tuberculosis infection, triggering the antimycobacterial mechanism of macrophages in synergism with TNF-␣ [46, 47] .
We hypothesize that in the initial steps of exposure, BCG can infect recluted DC precursors and induce them to differentiate into DCs with a mature phenotype producing proinflammatory cytokines that are responsible to amplify the response by promoting the recruitment of additional leukocytes. DCs derived from BCG-infected monocytes migrate to secondary lymphoid organs and produce high levels of IL-10, inducing a Th2-like immune response. These results could account for the inflammatory response induced by BCG vaccination and could explain one mechanism underlining the failure of the BCG vaccine to prevent pulmonary tuberculosis.
